Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
Tickers RHHBY SRPT
Tags why it's moving News Briefs
From Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
Tickers RHHBF RHHBY RHHVF
Tags General RHHBY News
From Benzinga
The Top 7 Growth Stocks in Biotech
Tickers APVO BEAM CMRX DVAX
Tags NASDAQ:ITOS,NASDAQ:VIR,NASDAQ:BEAM,NASDAQ:KNSA,OTCMKTS:RHHBY,NASDAQ:DVAX,NASDAQ:CMRX,NASDAQ:APVO CMRX RHHBY
From InvestorPlace
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
Tickers EXEL RHHBF RHHBY RHHVF
Tags News Briefs RHHBY
From Benzinga
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
Tickers RHHBY SRPT
Tags RHHBY Recent Press Releases Market News
From Motley Fool
3 Best Growth Stocks to Buy In March
Tickers HIMS IWF MELI RHHBY
Tags IWF VUG Market News
From Motley Fool
Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients
Tickers BPMC RHHBY
Tags Health Care RHHBY General
From Benzinga
Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines
Tickers BPMC RHHBF RHHBY RHHVF
Tags BPMC RHHBF RHHVF
From Benzinga
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
Tickers ABBV INFI MEIP MRK
Tags News Briefs Movers
From Benzinga
New Data Shows Roche's Vabysmo Improves Vision, Retinal Fluid In Retinal Disorder
Tickers REGN RHHBF RHHBY RHHVF
Tags RHHBF RHHVF News
From Benzinga
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
Tickers RHHBF RHHBY RHHVF
Tags Briefs News Large Cap
From Benzinga
Roche Flags Lower 2023 Sales On Declining Demand For COVID-19 Treatment, Diagnostics
Tickers RHHBF RHHBY RHHVF
Tags Benzinga Market News Health Care
From Benzinga
Roche Introduces Test To Detect Contagious XBB.1.5 Omicron Sub-Variant
Tickers RHHBF RHHBY
Tags RHHBY News Briefs
From Benzinga
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Tickers RHHBF RHHBY RHHVF
Tags RHHBF RHHVF General
From Benzinga
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
Tickers AERG ATLX CLNV CYDY
Tags ETHE RHHBY CLNV
From Benzinga
Europe Approves Xofluza, Roche's Revolutionary Influenza Antiviral with New Mechanism
Tickers RHHBF RHHBY RHHVF
Tags RHHBF RHHVF News
From Benzinga
Twitter Hackers Stole More Than 200M Emails, Delta Air Lines To Offer Free Wi-Fi, Bed Bath & Beyond's Bankruptcy Coming Sooner Than Expected: Top Stories Today
Tickers BBBY CRM DAL PFE
Tags TMUS Commodities RHHBY
From Benzinga
Roche's Investigational Lymphoma Candidate Goes Under FDA Priority Review
Tickers RHHBF RHHBY RHHVF
Tags RHHVF RHHBF Briefs
From Benzinga
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
Tickers GILD RHHBY
Tags Market News GILD Recent Press Releases
From Motley Fool
Roche's Follicular Lymphoma Therapy Scores FDA Approval
Tickers BIIB RHHBF RHHBY RHHVF
Tags FDA Benzinga Market News
From Benzinga
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
Tickers LLY RHHBF RHHBY RHHVF
Tags LLY FDA Benzinga
From Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
Tickers GILD MRK RCUS RHHBY
Tags RCUS NASDAQ:GILD,NYSE:RCUS,OTCMKTS:RHHBY,NYSE:MRK RHHBY
From InvestorPlace
OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
Tickers AAUKF ASMIY ATLX BDRBF
Tags FISOF CYDY CWGL
From Benzinga
Roche Presents New Data Demonstrating Potential Benefit Of Two Lymphoma Candidates
Tickers RHHBF RHHBY RHHVF
Tags RHHBY Health Care General
From Benzinga
Broadcom-Vmware Deal Draws European Regulatory Attention, Rivian Pauses Mercedes-Partnered EV Van Plans For Europe, Credit Suisse Issued Loan On Suspicious Bills: Top Stories Monday, Dec. 12
Tickers AAL AMGN AMKBY AMZN
Tags Biotech CS Cryptocurrency
From Benzinga
After 16 Years, Roche's Pharma Division Head Decides To Step Down
Tickers NSRGY RHHBF RHHBY RHHVF
Tags NSRGY RHHVF RHHBF
From Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
Tickers EXEL IPSEY RHHBY TAK
Tags Benzinga TAK Market News
From Benzinga
3 Hot Stocks That Could Live Up to Their Lofty Valuations
Tickers ABBV GMAB GTBIF JNJ
Tags Market News JNJ GTBIF
From Motley Fool
Replimune Shares Surge After Early Data From Pretreated Melanoma Patients
Tickers BMY REPL RHHBF RHHBY
Tags General RHHBY Briefs
From Benzinga
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
Tickers AMGN CHRS CYTK IBB
Tags ZLAB chemotherapy MRTX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.